Corcept Therapeutics | CORT - Trade Creditors


Corcept Therapeutics reported $34.45M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 21.75M 1.65M Sep/2025
Alaunos Therapeutics USD 843K 34K Sep/2025
ANI Pharmaceuticals USD 69.8M 15.23M Sep/2025
Ardelyx USD 18.39M 3.29M Sep/2025
Aurora Cannabis CAD 49.34M 31.94M Sep/2025
BioMarin Pharmaceutical USD 798.44M 114.19M Sep/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Canopy Growth CAD 18.14M 5.94M Sep/2025
Corcept Therapeutics USD 34.45M 10.92M Sep/2025
Eli Lilly USD 4.26B 186.5M Sep/2025
J&J USD 9.62B 161M Sep/2025
Merck USD 4.15B 102M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Pacira USD 17.69M 12.44M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Supernus Pharmaceuticals USD 108.61M 100.4M Sep/2025
TG Therapeutics USD 61.64M 72.38M Sep/2025